These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33737739)

  • 21. Daily briefing: Global COVID-19 vaccination gets a billion-dose boost.
    Graham F
    Nature; 2021 Jun; ():. PubMed ID: 34155391
    [No Abstract]   [Full Text] [Related]  

  • 22. Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19.
    Li Q; Wang J; Tang Y; Lu H
    Drug Discov Ther; 2021; 15(3):118-123. PubMed ID: 34234059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Creating Novel Surveillance Data Products for Briefing Health Department Leadership and Elected Officials During the COVID-19 Pandemic in Texas.
    Chapman LE; Cobb K; Hall E; Seidel S
    J Public Health Manag Pract; 2023 May-Jun 01; 29(3):403-410. PubMed ID: 36730022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Access to COVID-19 Vaccines: A New Global Approach.
    Bouderhem R
    Vaccines (Basel); 2022 Oct; 10(11):. PubMed ID: 36366304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape.
    Chakraborty C; Sharma AR; Bhattacharya M; Lee SS
    Front Immunol; 2021; 12():679344. PubMed ID: 34305909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges.
    Dhama K; Dhawan M; Tiwari R; Emran TB; Mitra S; Rabaan AA; Alhumaid S; Alawi ZA; Al Mutair A
    Hum Vaccin Immunother; 2022 Nov; 18(5):2045853. PubMed ID: 35258416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The changing health impact of vaccines in the COVID-19 pandemic: A modeling study.
    Cohen JA; Stuart RM; Panovska-Griffiths J; Mudimu E; Abeysuriya RG; Kerr CC; Famulare M; Klein DJ
    Cell Rep; 2023 Apr; 42(4):112308. PubMed ID: 36976678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Development and Evaluation about "2nd-wave" COVID-19 Vaccines].
    Araki Y
    Yakugaku Zasshi; 2022; 142(6):619-627. PubMed ID: 35650082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges and Recent Advancements in COVID-19 Vaccines.
    Wang SC; Rai CI; Chen YC
    Microorganisms; 2023 Mar; 11(3):. PubMed ID: 36985360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.
    Gong W; Parkkila S; Wu X; Aspatwar A
    Int Rev Immunol; 2023; 42(6):393-414. PubMed ID: 35635216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Briefing improves the management of a difficult mask ventilation in infants : Simulator study using Web-based decision support].
    St Pierre M; Breuer G; Strembski D; Schmitt C; Lütcke B
    Anaesthesist; 2016 Sep; 65(9):681-9. PubMed ID: 27565996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of increased mobility on SARS-CoV-2 transmission: a descriptive study of the trends of COVID-19 in Zimbabwe between December 2020 and January 2021.
    Murewanhema G; Burukai TV; Chiwaka L; Maunganidze F; Munodawafa D; Pote W; Mufunda J
    Pan Afr Med J; 2021; 39():125. PubMed ID: 34527141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Social Media Efficacy in Crisis Management: Effectiveness of Non-pharmaceutical Interventions to Manage COVID-19 Challenges.
    Zhou Y; Draghici A; Abbas J; Mubeen R; Boatca ME; Salam MA
    Front Psychiatry; 2021; 12():626134. PubMed ID: 35197870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Call to Action Against Persistent Lack of Transparency in Vaccine Pricing Practices During the COVID-19 Pandemic.
    Arguedas-Ramírez G
    Ann Glob Health; 2022; 88(1):87. PubMed ID: 36311897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ten years of the Global Alliance for Vaccines and Immunization: challenges and progress.
    Clemens J; Holmgren J; Kaufmann SH; Mantovani A
    Nat Immunol; 2010 Dec; 11(12):1069-72. PubMed ID: 21079627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and evaluation of 'briefing notes' as a novel knowledge translation tool to aid the implementation of sex/gender analysis in systematic reviews: a pilot study.
    Doull M; Welch V; Puil L; Runnels V; Coen SE; Shea B; O'Neill J; Borkhoff C; Tudiver S; Boscoe M
    PLoS One; 2014; 9(11):e110786. PubMed ID: 25372876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The art of balancing: the facilitator's role in briefing in simulation-based learning from the perspective of nursing students - a qualitative study.
    Solli H; Haukedal TA; Husebø SE; Reierson IÅ
    BMC Nurs; 2020; 19():99. PubMed ID: 33100906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expert Views on COVAX and Equitable Global Access to COVID-19 Vaccines.
    Manriquez Roa T; Holzer F; Luna F; Biller-Andorno N
    Int J Public Health; 2021; 66():1604236. PubMed ID: 35035347
    [No Abstract]   [Full Text] [Related]  

  • 39. International Efforts and Next Steps to Advance COVID-19 Vaccines Research and Production in Low- and Middle-Income Countries.
    Du L; Wang M; Raposo VL
    Vaccines (Basel); 2021 Dec; 10(1):. PubMed ID: 35062703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 Vaccine Collaborative Supply Planning: Is This the Next Frontier for Routine Immunization Supply Chains?
    Akhlaghi L; Prosser W; Rakotomanga A; Makena J; Azubike T; Bello Y; Emelike S; Mothetsi L; Motuba M; Olayemi V; Samba S; Suh S; Ramaroson S; Yarro FDN
    Glob Health Sci Pract; 2024 Feb; 12(Suppl 1):. PubMed ID: 38378271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.